Javascript must be enabled to continue!
Case Report: A rare phenomenon of venlafaxine induced vocal tics
View through CrossRef
Background
Venlafaxine is a serotonin norepinephrine reuptake inhibitor, an effective medication widely used in many psychiatric conditions, including major depressive disorder and generalized anxiety disorder. It is a relatively safe and tolerated medication. Despite that, it has some side effects affecting many systems, including nausea, insomnia, and tremors. Also, it has some neuropsychiatric side effects, such as akathisia. Venlafaxine induced akathisia has been reported in some studies. Several antidepressants have been associated with some neuropsychiatric manifestations, including tics, usually motor, but not vocal. In our study, we reported a rare side effect of venlafaxine, which is venlafaxine-induced vocal tics.
Case presentation
A 57-year-old women was diagnosed with anxiety and started on venlafaxine with a good response for three months. Then she stopped it. Her anxiety symptoms started to appear again. Then she re-initiated venlafaxine again. A few days afterwards she started to develop vocal tics that are frequent and distressing to the patient. The Yale Global Tic Severity Scale (YGTSS) score at presentation was 22 (Total Tic Score), indicating moderate severity, with an impairment score of 20. Causality assessment using the Naranjo Adverse Drug Reaction Probability Scale yielded a score of 7, indicating a probable relationship between and the vocal tics.
Discussion
To our knowledge, this appears to be the first reported case of venlafaxine induced vocal tics. On the other hand, there were previous reports on Sertraline and Mirtazapine. Previous studies reported associations of tics with SSRIs and atypical antidepressants but not SNRIs. Also, our study is the first study that reported “vocal” tics in association with antidepressant. The proposed mechanism involves a complex interaction between serotonergic augmentation and dopaminergic dysregulation in fronto-striatal circuits, in which increased serotonin levels may indirectly modulate dopamine concentrations to express tics in susceptible individuals.
Conclusion
Our findings suggest that venlafaxine may induce vocal tics. Physicians should consider venlafaxine as a potential cause when patients develop vocal tics while on treatment. Early detection and discontinuation of the medication can prevent complications and lead to symptom resolution.
Title: Case Report: A rare phenomenon of venlafaxine induced vocal tics
Description:
Background
Venlafaxine is a serotonin norepinephrine reuptake inhibitor, an effective medication widely used in many psychiatric conditions, including major depressive disorder and generalized anxiety disorder.
It is a relatively safe and tolerated medication.
Despite that, it has some side effects affecting many systems, including nausea, insomnia, and tremors.
Also, it has some neuropsychiatric side effects, such as akathisia.
Venlafaxine induced akathisia has been reported in some studies.
Several antidepressants have been associated with some neuropsychiatric manifestations, including tics, usually motor, but not vocal.
In our study, we reported a rare side effect of venlafaxine, which is venlafaxine-induced vocal tics.
Case presentation
A 57-year-old women was diagnosed with anxiety and started on venlafaxine with a good response for three months.
Then she stopped it.
Her anxiety symptoms started to appear again.
Then she re-initiated venlafaxine again.
A few days afterwards she started to develop vocal tics that are frequent and distressing to the patient.
The Yale Global Tic Severity Scale (YGTSS) score at presentation was 22 (Total Tic Score), indicating moderate severity, with an impairment score of 20.
Causality assessment using the Naranjo Adverse Drug Reaction Probability Scale yielded a score of 7, indicating a probable relationship between and the vocal tics.
Discussion
To our knowledge, this appears to be the first reported case of venlafaxine induced vocal tics.
On the other hand, there were previous reports on Sertraline and Mirtazapine.
Previous studies reported associations of tics with SSRIs and atypical antidepressants but not SNRIs.
Also, our study is the first study that reported “vocal” tics in association with antidepressant.
The proposed mechanism involves a complex interaction between serotonergic augmentation and dopaminergic dysregulation in fronto-striatal circuits, in which increased serotonin levels may indirectly modulate dopamine concentrations to express tics in susceptible individuals.
Conclusion
Our findings suggest that venlafaxine may induce vocal tics.
Physicians should consider venlafaxine as a potential cause when patients develop vocal tics while on treatment.
Early detection and discontinuation of the medication can prevent complications and lead to symptom resolution.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
A Pharmacokinetic Drug-Drug Interaction Study of Venlafaxine and Indinavir
A Pharmacokinetic Drug-Drug Interaction Study of Venlafaxine and Indinavir
Depression is a common occurrence in the human immunodeficiency virus (HIV)-infected population. Complications in treating depressed HIV-infected individuals include the use of mul...
The Development of a Vocal Teaching Model Based on Verdi Art Songs for Undergraduate Level in The People’s Republic of China
The Development of a Vocal Teaching Model Based on Verdi Art Songs for Undergraduate Level in The People’s Republic of China
This research aimed to develop a comprehensive vocal teaching model grounded in Giuseppe Verdi’s art music, tailored specifically for undergraduate music students in the People’s R...
Validation of the Italian version of the In-Person Telephone Interview for Cognitive Status (IP-TICS)
Validation of the Italian version of the In-Person Telephone Interview for Cognitive Status (IP-TICS)
Abstract
Background
This study validated the Italian version of the In-Person Telephone Interview for Cognitive Status (I...
Quetiapine associated tics in a pediatric patient post overdose on re-initiation: An interesting clinical scenario
Quetiapine associated tics in a pediatric patient post overdose on re-initiation: An interesting clinical scenario
The COVID-19 pandemic has led to a multitude of new medical and psychiatric complications and new presentations that were either never seen before or not seen to the extent that th...
Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine
Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor used as an antidepressant. Interindividual variability and herb-drug interactions can lead to drug-induced toxicity. We...
miR-204-5p Plays a Critical Role in the Pathogenesis of Depression
and Anti-depression Action of Venlafaxine in the Hippocampus of
Mice
miR-204-5p Plays a Critical Role in the Pathogenesis of Depression
and Anti-depression Action of Venlafaxine in the Hippocampus of
Mice
Background:
Venlafaxine has been demonstrated to treat diseases such as social anxiety
disorder and depression. Most of antidepressants including venlafaxine have a certain effect,...

